Preclinical Efficacy of Vascular Disrupting Agents in Non–Small-Cell Lung Cancer
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference75 articles.
1. Implications of key trials in advanced nonsmall cell lung cancer;Bonomi;Cancer,2010
2. Disrupting tumour blood vessels;Tozer;Nat Rev Cancer,2005
3. Vascular disrupting agents: a novel mechanism of action in the battle against non-small cell lung cancer;Gridelli;Oncologist,2009
4. Current results of the screening program at the Division of Cancer Treatment, National Cancer Institute;Goldin;Eur J Cancer,1981
5. Divergent activity of derivatives of amsacrine (m-AMSA) towards Lewis lung carcinoma and P388 leukaemia in mice;Baguley;Eur J Cancer Clin Oncol,1983
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tumor vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA): Suppresses macrophage capping protein beyond STING activation;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-06
2. Anti-tumor efficacy of CKD-516 in combination with radiation in xenograft mouse model of lung squamous cell carcinoma;BMC Cancer;2020-11-03
3. Detection of Hyperacute Reactions of Desacetylvinblastine Monohydrazide in a Xenograft Model Using Intravoxel Incoherent Motion DWI and R2* Mapping;American Journal of Roentgenology;2019-04
4. A vascular disrupting agent overcomes tumor multidrug resistance by skewing macrophage polarity toward the M1 phenotype;Cancer Letters;2018-04
5. A High Content Screen in Macrophages Identifies Small Molecule Modulators of STING-IRF3 and NFkB Signaling;ACS Chemical Biology;2018-03-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3